Immunologist Akiko Iwasaki: ‘We are not done with Covid, not even close’
The Yale professor and Long COVID expert gave a really interesting interview to The Guardian on why the virus is causing ongoing illness for…
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection
“In this analysis of data from 9764 participants in the RECOVER adult cohort, a prospective longitudinal cohort study,…
Myricetin possesses the potency against SARS-CoV-2 infection through blocking viral-entry facilitators and suppressing inflammation in rats and mice
This recent study showed that myricetin (3,5,7-trihydroxy-2-(3,4,5-tri hydroxyphenyl)-4-benzopyrone), a common flavonol extracted from many natural plants and Chinese…
SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase
A study by the University of Helsinki, carried out in the frame of the Long COVID project, has discovered the main…
Profiling post-COVID-19 condition across different variants of SARS-CoV-2: a prospective longitudinal study in unvaccinated wild-type, unvaccinated alpha-variant, and vaccinated delta-variant populations
Self-reported symptom studies rapidly increased understanding of SARS-CoV-2 during the COVID-19 pandemic and enabled monitoring of long-term effects…
WHO Statement on the antigen composition of COVID-19 vaccines
World Health Organization Technical Advisory Group on COVID19 vaccines (TAG-CO-VAC) statement Current COVID19 vaccines continue to be highly protective against severe disease…
Long COVID: The Persistence of SARS-CoV-2 in the Mucous Membranes May Be A Factor
In new research recently published by Nature Communication, teams from Inserm and Université Paris Cité médecine, in collaboration with Universidade…
APPG ON CORONAVIRUS: Long Covid – where are we now? (recording)
The UK All-Party Parliamentary Group (APPG) on Coronavirus, an independent cross-party group, aims to ensure that lessons are learned from the…